The Spectrum of Cutaneous and Systemic Manifestations Associated with Anti-PM/Scl: Insights from a Single Institution Case Series

J Am Acad Dermatol. 2025 Jan 3:S0190-9622(25)00005-2. doi: 10.1016/j.jaad.2024.12.033. Online ahead of print.
No abstract available

Keywords: anti-PM/Scl; dermatomyositis; idiopathic inflammatory myopathy; interstitial lung disease; polymyositis; scleroderma; scleroderma/myositis overlap disease; scleromyositis.